Receptors, Interleukin-1 Type I
                             
                            
                            
                                
                            
                            
                                
                            
                            
                            
                                
                                    
                                            
	"Receptors, Interleukin-1 Type I" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, 
	MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, 
	which enables searching at various levels of specificity.
	
	
		
			
			
				An interleukin-1 receptor subtype that is involved in signaling cellular responses to INTERLEUKIN-1ALPHA and INTERLEUKIN-1BETA. The binding of this receptor to its ligand causes its favorable interaction with INTERLEUKIN-1 RECEPTOR ACCESSORY PROTEIN and the formation of an activated receptor complex.
    
			
			
				
				
					
						| Descriptor ID | D053573 | 
					
						| MeSH Number(s) | D12.776.543.750.705.852.420.300.500 | 
					
						| Concept/Terms | Receptors, Interleukin-1 Type IReceptors, Interleukin-1 Type IReceptors, Interleukin 1 Type ICD121a AntigensReceptor Type I, Interleukin-1Receptor Type I, Interleukin 1Interleukin-1 Receptor Type IInterleukin 1 Receptor Type IAntigens, CDw121aCDw121a AntigensInterleukin-1 Receptors Type IInterleukin 1 Receptors Type I
 | 
					
				
			 
			
				Below are MeSH descriptors whose meaning is more general than "Receptors, Interleukin-1 Type I".
				
			 
			
			
				Below are MeSH descriptors whose meaning is more specific than "Receptors, Interleukin-1 Type I".
				
			 
		 
	 
 
                                        
                                            
	
	
		
			
			
					
				This graph shows the total number of publications written about "Receptors, Interleukin-1 Type I" by people in this website by year, and whether "Receptors, Interleukin-1 Type I" was a major or minor topic of these publications. 
				
					 
                    To see the data from this visualization as text, 
click here. 
                
		            | Year | Major Topic | Minor Topic | Total | 
|---|
| 2008 | 2 | 0 | 2 | 
| 2014 | 0 | 1 | 1 | 
                    To return to the timeline, 
click here.
                 
			 	
			
			
			
			
				Below are the most recent publications written about "Receptors, Interleukin-1 Type I" by people in Profiles.
						
					
								- 
								Telomere length sensitive regulation of interleukin receptor 1 type 1 (IL1R1) by the shelterin protein TRF2 modulates immune signalling in the tumour microenvironment. Elife. 2024 Dec 27; 13. 
- 
								Tumor-Associated Fatigue in Cancer Patients Develops Independently of IL1 Signaling. Cancer Res. 2018 02 01; 78(3):695-705. 
- 
								Adenosine through the A2A adenosine receptor increases IL-1? in the brain contributing to anxiety. Brain Behav Immun. 2014 Oct; 41:218-31. 
- 
								Unexpected role for IL-17 in protective immunity against hypervirulent Mycobacterium tuberculosis HN878 infection. PLoS Pathog. 2014 May; 10(5):e1004099. 
- 
								IL-1 induces proinflammatory leukocyte infiltration and regulates fibroblast phenotype in the infarcted myocardium. J Immunol. 2013 Nov 01; 191(9):4838-48. 
- 
								Characterization of interleukin-1? in Helicobacter pylori-induced gastric inflammation and DNA methylation in interleukin-1 receptor type 1 knockout (IL-1R1(-/-)) mice. Eur J Cancer. 2013 Aug; 49(12):2760-70. 
- 
								Hypoxia/reoxygenation impairs memory formation via adenosine-dependent activation of caspase 1. J Neurosci. 2012 Oct 03; 32(40):13945-55. 
- 
								The role of IL-1 in the pathogenesis of heart disease. Arch Immunol Ther Exp (Warsz). 2009 May-Jun; 57(3):165-76. 
- 
								Interleukin-1 receptor-1-deficient mice show attenuated production of ocular surface inflammatory cytokines in experimental dry eye. Cornea. 2008 Aug; 27(7):811-7. 
- 
								Interleukin-1 receptor type I signaling critically regulates infarct healing and cardiac remodeling. Am J Pathol. 2008 Jul; 173(1):57-67.